Use of a PPAR-alpha agonist to treat weight gain associated with a PPARgamma agonist treatment
Details for Australian Patent Application No. 2003260380 (hide)
International Classifications
Event Publications
20 November 2003 Complete Application Filed
Priority application(s): 02291994.8 08.08.02 EP; 02292830.3 14.11.02 EP
22 April 2004 Application Open to Public Inspection
Published as AU-B-2003260380
1 March 2007 Assignment before Grant
Laboratories Fournier S.A. The application has been assigned to Fournier Laboratoires Ireland Ltd.
14 June 2007 Change of Name(s) of Applicant(s), Section 104
Fournier Laboratoires Ireland Ltd The name of the applicant has been changed to Fournier Laboratories Ireland Ltd
26 July 2007 Change of Name(s) of Applicant(s), Section 104
Fournier Laboratories Ireland Ltd The name of the applicant has been changed to FOURNIER LABORATORIES IRELAND LIMITED
6 November 2008 Application Accepted
Published as AU-B-2003260380
5 March 2009 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2003260379-METHOD FOR THE PRODUCTION OF 2-((DIMETHYLAMINO)METHYL)-1-(3METHOXYPHENYL)CYCLOHEXANOL
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser